Join the Benicar group to help and get support from people like you.
Benicar News
FDA Medwatch Alert: Olmesartan: Drug Safety Communication - FDA Review Finds Cardiovascular Risks for Diabetics Not Conclusive
Includes: Benicar, Benicar HCT, Azor, Tribenzor, and Generics [Posted 06/24/2014] ISSUE: FDA has completed its safety review and has found no clear evidence of increased cardiovascular risks...
FDA Medwatch Alert: Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
ISSUE: FDA is warning that the blood pressure drug Olmesartan Medoxomil (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) can cause intestinal problems known as sprue-like...
FDA Medwatch Alert: Angiotensin Receptor Blockers (ARBs): Drug Safety Communication - Drug Safety Review Completed
[UPDATED 06/02/2011] FDA’s meta-analysis of 31 randomized controlled trials comparing ARBs to other treatment found no evidence of an increased risk of incident (new) cancer, cancer-related death, b...
FDA Medwatch Alert: Benicar (olmesartan): Ongoing Safety Review
[UPDATED 04/14/2011] After reviewing the results of the ROADMAP and ORIENT trials, FDA has determined that the benefits of Benicar continue to outweigh its potential risks when used for the treatment...
FDA Approves Benicar for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
PARSIPPANY, N.J., Feb. 11 /PRNewswire/ – Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar (olmesartan medoxomil)...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
High Blood Pressure, Hypertension